Mirati Therapeutics, Inc. (MRTX) Posts Q2 Loss of 82c/Share
Tweet
Share
E-mailGet Alerts MRTX Hot Sheet
Join SI Premium – FREE
Mirati Therapeutics, Inc. (NASDAQ: MRTX) reported Q2 EPS of ($0.82), $0.13 worse than the analyst estimate of ($0.69).
For earnings history and earnings-related data on Mirati Therapeutics, Inc. (MRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Owlet (OWLT) Tops Q2 EPS by 9c
- Transact Technologies (TACT) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
